the public's readiness dropped. This sharp decline followed an announcement by AstraZeneca that its vaccine trials were halted because of adverse participant reactions.
Additionally, statements by President Donald Trump and Democratic vice presidential nominee Kamala Harris may have affected Americans' views.
Trump said in early September that a vaccine could be available before Election Day, raising questions about pressure being put on the FDA to expedite approval.